Grants per year
- 50 - 75 out of 1,104 results
Search results
-
Finished
-
Prot #19774: A multicenter Phase 1 study to evaluate the safety, tolerability, pharmacokinetics, and maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of the combination of rogaratinib and copanlisib in patients with FGFR-positive, local
Bayer HealthCare Pharmaceuticals, Inc.
10/18/18 → 5/19/21
Project: Research project
-
Prot #ASTX660-01: Phase 1-2 Study of the Safety, Pharmacokinetics, and Preliminary Activity of ASTX660 in Subjects with Advanced Solid Tumors and Lymphomas
Pro, B.
10/17/18 → 10/17/21
Project: Research project
-
Coleman 4R Patient Care Sequences for Cancer and Supportive Care
Garcia, S. F. & Gradishar, W. J.
10/1/18 → 12/31/21
Project: Research project
-
-
-
Targeting alpha B-Crystallin in Basal-like Breast Cancer
University of Wisconsin-Madison, Breast Cancer Research Foundation
10/1/18 → 9/30/19
Project: Research project
-
Prot #BLU-285-1303: An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients with Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
Agulnik, M.
Syneos Health, Inc., Blueprint Medicines Corporation
9/20/18 → 9/20/21
Project: Research project
-
Targeting pro-metastatic neutrophils to inhibit breast cancer metastasis
Liu, X. & Cristofanilli, M.
Susan G. Komen Breast Cancer Foundation
9/12/18 → 12/31/19
Project: Research project
-
Prot #MCLA-128-CL02: Phase 2 Study of MCLA-128-based Combinations in Metastatic Breast Cancer (MBC): MCLA-128/Trastuzumab/Chemotherapy in HER2-Positive MBC and MCLA-128/Endocrine Therapy in Estrogen Receptor Positive and Low HER2 Expression MBC
SCRI Development Innovations, LLC, Merus N.V.
8/7/18 → 8/7/21
Project: Research project
-
-
Development of OncoLink: A Web-Based irAE Monitoring Platform
Yanez, B. R., Mohindra, N. A., Penedo, F. J. & Sosman, J. A.
American Cancer Society, Bristol-Myers Squibb Company
7/1/18 → 12/31/20
Project: Research project
-
Development of OncoLink: A Web-Based irAE Monitoring Platform
Yanez, B. R., Mohindra, N. A., Penedo, F. J. & Sosman, J. A.
Melanoma Research Alliance Foundation, Bristol-Myers Squibb Company
7/1/18 → 7/31/21
Project: Research project
-
Molecular mechanisms of relapse after therapy discontinuation in chronic myeloid leukemia
American Society of Hematology
7/1/18 → 12/31/19
Project: Research project
-
Development of OncoLink: A Technology-Assisted irAE Monitoring Platform
Yanez, B. R., Mohindra, N. A., Penedo, F. J. & Sosman, J. A.
Melanoma Research Alliance Foundation
7/1/18 → 7/31/21
Project: Research project
-
Development of OncoLink: A Technology-Assisted irAE Monitoring Platform
Yanez, B. R., Mohindra, N. A., Penedo, F. J. & Sosman, J. A.
7/1/18 → 7/31/21
Project: Research project
-
Assessing the Effect of Specific TGF-B1 Inhibitor in Myelofibrosis
Crispino, J. D.
6/8/18 → 7/31/19
Project: Research project
-
Prot #ANG-002: HOMING Study: Harvest of Circulating Tumor Cells (CTCs) from Patients with Metastatic Breast Cancer (MBC) Using the ParsortixTM PC1 System
Cristofanilli, M.
5/11/18 → 5/11/21
Project: Research project
-
Prot #CO40016: A Double-Blind, Placebo-Controlled, Randomized Phase III Study Of Ipatasertib In Combination With Paclitaxel As A Treatment For Patients With Pik3ca/Akt1/Pten-Altered, Locally Advanced Or Metastatic, Triple-Negative Breast Cancer Or Hormone
Syneos Health, Inc., Genentech, Inc.
4/19/18 → 4/19/21
Project: Research project
-
Harnessing Druggable Synthetic Lethal Interactions in Triple-Negative Breast Cancer with Elevated MYC Expression
Horiuchi, D., Mendillo, M. L., Santa-Maria, C. A. & Vasilopoulos, A.
U.S. Army Medical Research and Materiel Command
4/1/18 → 3/31/22
Project: Research project